Professor Ruth Roberts is guest speaker at the 22nd Annual John Doull Toxicology Symposium. This event is taking place on the 29th of September at 9am CDT. The Symposium is part of the University of Kansas, School of Medicine, Pharmacology, Toxicology & Therapeutics' series of seminars. Attendance is limited but if you are interested please [...]
Dr Michael Morton will be attending the annual Safety Pharmacology Society Meeting being held virtually this year between 14th and 17th of September. Mike will be presenting Poster 030: Electrophysiological analysis of Seroquel’s activity in sodium ion channels, CiPA ion channels and hiPSC-neuronal cells K L Rockley1; K Jones1; R A Roberts1; M J Morton1 [...]
ApconiX is delighted to welcome Dr Duncan Armstrong to the team. Duncan has expert knowledge in molecular pharmacology, preclinical safety pharmacology and secondary pharmacodynamics gained over 18 years working in drug discovery and development at AstraZeneca UK and Novartis USA. He has worked with project teams across multiple therapy areas and at all stages of [...]
Join Dr Richard Knight, Co-founder and Director of ApconiX, Dr Peter Warn consultant at Magic Bullet Consulting, and Aleksander Danilovski, Chief Scientific Officer & Senior Vice President, Global R&D and Regulatory Affairs at Xelia at the 4th AMR Conference as they discuss the "Top 10 Mistakes in Antibacterial Development". In view of the continuing uncertain situation [...]
Join Professor Ruth Roberts for the next science webinar in the Alderley Park Science Seminar Series: Science-Driven Design of the Preclinical Strategy: Case by Case Tuesday, 11 August 2020 12:00 pm to 1:00 pm Ruth will present lessons learned from >20 years’ experience in the pharmaceutical industry focusing on attrition, prediction and the challenges posed by nonclinical [...]
Professor Ruth Roberts, Dr Claire Sadler and Dr Leigh Ann Burns Nass present Target Safety Assessments: Knowledge is Power webinar in a SOT 2020 Exhibitor Hosted Session. Membership of SOT is not required. Registration for the webinar is free.
ApconiX is delighted to welcome Dr Laurence Bishop to the team as our Head of Business Development. Laurence is an experienced DMPK and toxicological scientist with 20 years’ experience of nonclinical drug development. Specialising in business development for the past 13 years, we are looking forward to Laurence playing a key role in our growth [...]
ApconiX is pleased to announce that Dr Guy Healing has been appointed to an Honorary Professorship in the School of Pharmacy at the University of East Anglia (UEA), Norwich, UK. Guy first became involved with the UEA when he worked for AstraZeneca. One of the University’s PhD projects was co-sponsored by AstraZeneca and Guy was [...]
ApconiX welcomes Dr Selvan Bavan, who joins us to carry out ion channel research using manual patch-clamp while learning more about using automated patch-clamp by working with Dr Michael Morton and Dr Karen Jones. Selvan commented, “Conventional manual patch-clamp is regarded as a ‘gold standard’ technique to record ion channel currents, but this technique has [...]
As we all continue to live through these very difficult times, our main priority is the safety and wellbeing of our staff, their families and the community. As an essential facility in the development of new medicines, we remain fully operational. We are following government guidelines and are keeping all our clients updated as the [...]
